With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Clinton de Souza, Project Lead, Partnership for Supply Chain Management (PFSCM)
Dominique Baabo, National Coordinator, Health Systems Strengthening Project, Ministry of Health, Democratic Republic of the Congo
Ann Allen, Program Officer - Systems Innovation, Bill & Melinda Gates Foundation
Lombe Kasonde, Health Specialist, World Bank
James Maloney, Chief, Supply Chain for Health Division, Global Health Bureau, U.S. Agency for International Development
Mark Parrish, President, International Federation of Pharmaceutical Wholesalers (IFPW)
John Simon, Founding Partner, Total Impact Capital and former US Ambassador to the African Union
• Prashant Yadav, Visiting Fellow, Center for Global Development and Professor, INSEAD
ABOUT THE EVENT
Join the Center for Global Development for a presentation and panel discussion on the role of private wholesalers and distributors in global health supply chains to improve access to medicines.
Private wholesalers and distributors are the mainstay of health product distribution in most OECD countries. Retail and hospital pharmacies place their orders for the medicines and health products they need with their selected distributors, and the distributors deliver the orders, often daily. However, private wholesalers and distributors have received considerably less attention in health care supply chains in low- and middle-income countries (LMICs). While this is partially due to a highly fragmented wholesaler and distributor landscape and weak technical capacity, it is also driven by a lack of understanding of the capabilities of wholesalers and distributors operating in LMICs.
This event will start with a presentation of the latest findings by Clinton de Souza regarding the technical and operational capabilities of existing wholesalers and distributors and their potential to improve the efficiency and effectiveness of global health supply chains. The presentation will be followed by an interactive panel discussion with key stakeholders to highlight the current thinking of global policymakers regarding the potential role of private wholesalers and distributors in achieving reliable, affordable, and high-quality supply of health products in LMICs.
Please join us for a reception following the panel.
The digital transformation of the global economy can help businesses and governments provide services more efficiently and effectively. But it also creates new risks for individuals whose personal data may be used to improve products and services.
Please join us to discuss the new IDRC book Scaling Impact: Innovation for the Public Good. Co-authors, Robert McLean and John Gargani, will discuss the new and practical approach to scaling the positive impacts of research and innovation outlined in the book, based on a review of over 200 IDRC studies and 5 in-depth case explorations.
Health systems around the world can suffer from a crisis of distrust; patients may question the quality of government clinics and newspapers may expose private hospitals for peddling unnecessary procedures. These are symptoms of volume-based health systems that focus on the quantity of care delivered rather than quality or outcomes. Many countries are accelerating down this path. Hospital construction sometimes surpasses growth of primary care infrastructure. New insurance schemes sometimes expand access to inpatient treatment, without equivalent expansion of community-based prevention. These approaches create lasting structural flaws which increase costs without delivering desired results. As countries commit to universal health coverage (UHC), there is a narrow window to chart a different trajectory toward the common goal of achieving the best health outcomes for the resources invested.
The Chinese government’s Belt and Road initiative, now entering its 7th year, has generated a great deal of attention globally. The visibility of the initiative reflects its priority among China’s senior leadership, the consideration of the initiative as both opportunity and risk among potential partner governments, and the concerns raised by its critics. The discourse to date has been dominated by political and strategic considerations. The economics of BRI has received considerably less attention, partly a function of the lack of analysis and research on economic questions – but that picture is changing.
In 2016, the Liberian government delegated management of 93 randomly-selected public schools to private providers. The program has become an important case study in the design and management of public-private partnerships in the developing world, and a lightning rod for controversy.
The World Health Organization has declared a need for smarter spending strategies to achieve the Sustainable Development Goals. But what does ‘spending smarter’ mean? Should we prioritize TB screening and treatment or improved coverage of basic surgical services? What happens when we care about multiple aims, like population health outcomes and patient out-of-pocket health expenditures? Rarely are the same interventions the ‘best buys’ across all dimensions of interest. In this talk, Kate Lofgren will explore how mathematical optimization can formally account for multiple objectives and inform public financing decisions. Spending smarter can mean different decisions depending on the objective(s).